Fumarate in membranous nephropathy: more questions than answers
- 1 September 2021
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 100 (3), 707
- https://doi.org/10.1016/j.kint.2021.03.035
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathyKidney International, 2020
- Renal expression and urinary excretion of Na+/dicarboxylate cotransporter 1 (NaDC1) in obstructive nephropathy: a candidate biomarker for this pathologyPflügers Archiv - European Journal of Physiology, 2018
- Sodium-coupled dicarboxylate and citrate transporters from the SLC13 familyPflügers Archiv - European Journal of Physiology, 2013
- Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation statusThe Journal of Pathology, 2011
- Oat5 and NaDC1 Protein Abundance in Kidney and Urine After Renal Ischemic Reperfusion InjuryJournal of Histochemistry & Cytochemistry, 2008
- Generation and characterization of sodium-dicarboxylate cotransporter-deficient miceKidney International, 2007